Srgap3 Mouse (1->4)-beta-D-glucan multiple interactions EXP 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of SRGAP3 mRNA CTD PMID:36331819 Srgap3 Mouse 1,2-dichloroethane affects expression EXP 6480464 ethylene dichloride affects the expression of SRGAP3 mRNA CTD PMID:28960355 Srgap3 Mouse 1,2-dimethylhydrazine decreases expression EXP 6480464 1 and 2-Dimethylhydrazine results in decreased expression of SRGAP3 mRNA CTD PMID:22206623 Srgap3 Mouse 17beta-estradiol affects expression ISO SRGAP3 (Homo sapiens) 6480464 Estradiol affects the expression of SRGAP3 mRNA CTD PMID:25321415 Srgap3 Mouse 17beta-estradiol multiple interactions ISO SRGAP3 (Homo sapiens) 6480464 [Estradiol co-treated with TGFB1 protein] results in decreased expression of SRGAP3 mRNA CTD PMID:30165855 Srgap3 Mouse 17beta-estradiol decreases expression ISO Srgap3 (Rattus norvegicus) 6480464 Estradiol results in decreased expression of SRGAP3 mRNA CTD PMID:26945725 Srgap3 Mouse 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of SRGAP3 mRNA CTD PMID:26377647 Srgap3 Mouse 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO Srgap3 (Rattus norvegicus) 6480464 Tetrachlorodibenzodioxin results in decreased expression of SRGAP3 mRNA CTD PMID:33387578 and PMID:34747641 Srgap3 Mouse 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of SRGAP3 mRNA CTD PMID:28922406 Srgap3 Mouse 2-deoxy-D-glucose decreases expression ISO SRGAP3 (Homo sapiens) 6480464 Deoxyglucose results in decreased expression of SRGAP3 mRNA CTD PMID:33770205 Srgap3 Mouse 4,4'-sulfonyldiphenol increases expression ISO SRGAP3 (Homo sapiens) 6480464 bisphenol S results in increased expression of SRGAP3 mRNA CTD PMID:27685785 Srgap3 Mouse 4-hydroxyphenyl retinamide increases expression EXP 6480464 Fenretinide results in increased expression of SRGAP3 mRNA CTD PMID:28973697 Srgap3 Mouse aflatoxin B1 decreases expression EXP 6480464 Aflatoxin B1 results in decreased expression of SRGAP3 mRNA CTD PMID:19770486 Srgap3 Mouse aflatoxin B1 increases methylation ISO SRGAP3 (Homo sapiens) 6480464 Aflatoxin B1 results in increased methylation of SRGAP3 gene and Aflatoxin B1 results in increased methylation of SRGAP3 intron CTD PMID:27153756 and PMID:30157460 Srgap3 Mouse Aflatoxin B2 alpha decreases methylation ISO SRGAP3 (Homo sapiens) 6480464 aflatoxin B2 results in decreased methylation of SRGAP3 intron CTD PMID:30157460 Srgap3 Mouse alpha-Zearalanol multiple interactions ISO Srgap3 (Rattus norvegicus) 6480464 [Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of SRGAP3 mRNA CTD PMID:35163327 Srgap3 Mouse antimycin A decreases expression ISO SRGAP3 (Homo sapiens) 6480464 Antimycin A results in decreased expression of SRGAP3 mRNA CTD PMID:33770205 Srgap3 Mouse arsane multiple interactions ISO SRGAP3 (Homo sapiens) 6480464 [sodium arsenate results in increased abundance of Arsenic] which results in increased expression of SRGAP3 mRNA CTD PMID:32525701 Srgap3 Mouse arsenic atom multiple interactions ISO SRGAP3 (Homo sapiens) 6480464 [sodium arsenate results in increased abundance of Arsenic] which results in increased expression of SRGAP3 mRNA CTD PMID:32525701 Srgap3 Mouse arsenite(3-) multiple interactions ISO SRGAP3 (Homo sapiens) 6480464 arsenite inhibits the reaction [G3BP1 protein binds to SRGAP3 mRNA] CTD PMID:32406909 Srgap3 Mouse atrazine decreases expression ISO Srgap3 (Rattus norvegicus) 6480464 Atrazine results in decreased expression of SRGAP3 mRNA CTD PMID:36841081 Srgap3 Mouse benzo[a]pyrene multiple interactions EXP 6480464 Benzo(a)pyrene promotes the reaction [AHR protein binds to SRGAP3 promoter] CTD PMID:19654925 Srgap3 Mouse benzo[a]pyrene affects methylation ISO SRGAP3 (Homo sapiens) 6480464 Benzo(a)pyrene affects the methylation of SRGAP3 3' UTR more ... CTD PMID:27901495 and PMID:30157460 Srgap3 Mouse benzo[a]pyrene decreases expression EXP 6480464 Benzo(a)pyrene results in decreased expression of SRGAP3 mRNA CTD PMID:19770486 and PMID:21569818 Srgap3 Mouse benzo[e]pyrene decreases methylation ISO SRGAP3 (Homo sapiens) 6480464 benzo(e)pyrene results in decreased methylation of SRGAP3 intron CTD PMID:30157460 Srgap3 Mouse Benzo[k]fluoranthene decreases expression EXP 6480464 benzo(k)fluoranthene results in decreased expression of SRGAP3 mRNA CTD PMID:26377693 Srgap3 Mouse bis(2-ethylhexyl) phthalate decreases expression ISO SRGAP3 (Homo sapiens) 6480464 Diethylhexyl Phthalate results in decreased expression of SRGAP3 mRNA CTD PMID:31163220 Srgap3 Mouse bisphenol A increases expression ISO SRGAP3 (Homo sapiens) 6480464 bisphenol A results in increased expression of SRGAP3 mRNA CTD PMID:27685785 Srgap3 Mouse bisphenol A multiple interactions ISO SRGAP3 (Homo sapiens) 6480464 [bisphenol A co-treated with Fulvestrant] affects the methylation of SRGAP3 gene CTD PMID:31601247 Srgap3 Mouse bisphenol A increases methylation ISO SRGAP3 (Homo sapiens) 6480464 bisphenol A results in increased methylation of SRGAP3 gene CTD PMID:31601247 Srgap3 Mouse bisphenol A decreases expression ISO SRGAP3 (Homo sapiens) 6480464 bisphenol A results in decreased expression of SRGAP3 mRNA CTD PMID:31715268 Srgap3 Mouse bisphenol A increases methylation EXP 6480464 bisphenol A results in increased methylation of SRGAP3 promoter CTD PMID:27312807 Srgap3 Mouse bisphenol A increases expression ISO Srgap3 (Rattus norvegicus) 6480464 bisphenol A results in increased expression of SRGAP3 mRNA CTD PMID:30816183 Srgap3 Mouse camptothecin decreases expression ISO SRGAP3 (Homo sapiens) 6480464 Camptothecin results in decreased expression of SRGAP3 mRNA CTD PMID:33770205 Srgap3 Mouse carbon nanotube decreases expression EXP 6480464 Nanotubes more ... CTD PMID:25554681 Srgap3 Mouse CGP 52608 multiple interactions ISO SRGAP3 (Homo sapiens) 6480464 CGP 52608 promotes the reaction [RORA protein binds to SRGAP3 gene] CTD PMID:28238834 Srgap3 Mouse chlorpyrifos increases expression EXP 6480464 Chlorpyrifos results in increased expression of SRGAP3 mRNA CTD PMID:37019170 Srgap3 Mouse cisplatin multiple interactions ISO SRGAP3 (Homo sapiens) 6480464 [Cisplatin co-treated with jinfukang] results in increased expression of SRGAP3 mRNA CTD PMID:27392435 Srgap3 Mouse cisplatin increases expression ISO SRGAP3 (Homo sapiens) 6480464 Cisplatin results in increased expression of SRGAP3 mRNA CTD PMID:27392435 Srgap3 Mouse clobetasol decreases expression EXP 6480464 Clobetasol results in decreased expression of SRGAP3 mRNA CTD PMID:27462272 Srgap3 Mouse copper(II) chloride decreases expression ISO SRGAP3 (Homo sapiens) 6480464 cupric chloride results in decreased expression of SRGAP3 mRNA CTD PMID:38568856 Srgap3 Mouse cyclosporin A increases methylation ISO SRGAP3 (Homo sapiens) 6480464 Cyclosporine results in increased methylation of SRGAP3 promoter CTD PMID:27989131 Srgap3 Mouse cytarabine increases expression ISO SRGAP3 (Homo sapiens) 6480464 Cytarabine results in increased expression of SRGAP3 mRNA CTD PMID:21198554 and PMID:33770205 Srgap3 Mouse dexamethasone increases expression ISO SRGAP3 (Homo sapiens) 6480464 Dexamethasone results in increased expression of SRGAP3 mRNA CTD PMID:23137833 Srgap3 Mouse dextran sulfate multiple interactions EXP 6480464 [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of SRGAP3 mRNA CTD PMID:29950665 Srgap3 Mouse dextran sulfate decreases expression EXP 6480464 Dextran Sulfate results in decreased expression of SRGAP3 mRNA CTD PMID:35093514 Srgap3 Mouse dibenz[a,h]anthracene decreases expression EXP 6480464 1 more ... CTD PMID:26377693 Srgap3 Mouse Dibutyl phosphate affects expression ISO SRGAP3 (Homo sapiens) 6480464 di-n-butylphosphoric acid affects the expression of SRGAP3 mRNA CTD PMID:37042841 Srgap3 Mouse dibutyl phthalate decreases expression EXP 6480464 Dibutyl Phthalate results in decreased expression of SRGAP3 mRNA CTD PMID:17361019 and PMID:21266533 Srgap3 Mouse dorsomorphin multiple interactions ISO SRGAP3 (Homo sapiens) 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SRGAP3 mRNA CTD PMID:27188386 Srgap3 Mouse endosulfan decreases expression ISO Srgap3 (Rattus norvegicus) 6480464 Endosulfan results in decreased expression of SRGAP3 mRNA CTD PMID:29391264 Srgap3 Mouse ethanol affects splicing EXP 6480464 Ethanol affects the splicing of SRGAP3 mRNA CTD PMID:30319688 Srgap3 Mouse fluoranthene multiple interactions EXP 6480464 [1-methylanthracene co-treated with fluoranthene] results in increased expression of SRGAP3 mRNA CTD PMID:28329830 Srgap3 Mouse folic acid increases expression EXP 6480464 Folic Acid results in increased expression of SRGAP3 mRNA CTD PMID:25629700 Srgap3 Mouse FR900359 increases phosphorylation ISO SRGAP3 (Homo sapiens) 6480464 FR900359 results in increased phosphorylation of SRGAP3 protein CTD PMID:37730182 Srgap3 Mouse fulvestrant multiple interactions ISO SRGAP3 (Homo sapiens) 6480464 [bisphenol A co-treated with Fulvestrant] affects the methylation of SRGAP3 gene CTD PMID:31601247 Srgap3 Mouse gentamycin decreases expression ISO Srgap3 (Rattus norvegicus) 6480464 Gentamicins results in decreased expression of SRGAP3 mRNA CTD PMID:33387578 Srgap3 Mouse HC toxin increases expression ISO SRGAP3 (Homo sapiens) 6480464 HC toxin results in increased expression of SRGAP3 mRNA CTD PMID:33770205 Srgap3 Mouse inulin multiple interactions EXP 6480464 [perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of SRGAP3 mRNA CTD PMID:36331819 Srgap3 Mouse lipopolysaccharide multiple interactions ISO SRGAP3 (Homo sapiens) 6480464 S-(1 and 2-dichlorovinyl)cysteine inhibits the reaction [Lipopolysaccharides results in decreased expression of SRGAP3 mRNA] CTD PMID:35811015 Srgap3 Mouse lipopolysaccharide decreases expression ISO SRGAP3 (Homo sapiens) 6480464 Lipopolysaccharides results in decreased expression of SRGAP3 mRNA CTD PMID:35811015 Srgap3 Mouse methapyrilene decreases methylation ISO SRGAP3 (Homo sapiens) 6480464 Methapyrilene results in decreased methylation of SRGAP3 intron CTD PMID:30157460 Srgap3 Mouse methylmercury chloride decreases expression ISO SRGAP3 (Homo sapiens) 6480464 methylmercuric chloride results in decreased expression of SRGAP3 mRNA CTD PMID:28001369 Srgap3 Mouse nickel atom decreases expression ISO SRGAP3 (Homo sapiens) 6480464 Nickel results in decreased expression of SRGAP3 mRNA CTD PMID:25583101 Srgap3 Mouse nitrofen decreases expression ISO Srgap3 (Rattus norvegicus) 6480464 nitrofen results in decreased expression of SRGAP3 mRNA CTD PMID:33484710 Srgap3 Mouse ozone multiple interactions EXP 6480464 [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of SRGAP3 mRNA and [Air Pollutants results in increased abundance of Ozone] which results in increased expression of SRGAP3 mRNA CTD PMID:34911549 Srgap3 Mouse paracetamol decreases expression ISO Srgap3 (Rattus norvegicus) 6480464 Acetaminophen results in decreased expression of SRGAP3 mRNA CTD PMID:33387578 Srgap3 Mouse paraquat decreases expression ISO Srgap3 (Rattus norvegicus) 6480464 Paraquat results in decreased expression of SRGAP3 mRNA CTD PMID:32680482 Srgap3 Mouse perfluorooctane-1-sulfonic acid multiple interactions EXP 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of SRGAP3 mRNA and [perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of SRGAP3 mRNA CTD PMID:36331819 Srgap3 Mouse perfluorooctanoic acid multiple interactions ISO Srgap3 (Rattus norvegicus) 6480464 [Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of SRGAP3 mRNA CTD PMID:35163327 Srgap3 Mouse perfluorooctanoic acid increases expression ISO SRGAP3 (Homo sapiens) 6480464 perfluorooctanoic acid results in increased expression of SRGAP3 mRNA CTD PMID:36326898 Srgap3 Mouse perfluorooctanoic acid decreases expression EXP 6480464 perfluorooctanoic acid results in decreased expression of SRGAP3 mRNA CTD PMID:30711707 Srgap3 Mouse phenobarbital affects expression EXP 6480464 Phenobarbital affects the expression of SRGAP3 mRNA CTD PMID:23091169 Srgap3 Mouse phenylmercury acetate decreases expression ISO SRGAP3 (Homo sapiens) 6480464 Phenylmercuric Acetate results in decreased expression of SRGAP3 mRNA CTD PMID:26272509 Srgap3 Mouse phenylmercury acetate multiple interactions ISO SRGAP3 (Homo sapiens) 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SRGAP3 mRNA CTD PMID:27188386 Srgap3 Mouse prothioconazole increases expression ISO SRGAP3 (Homo sapiens) 6480464 prothioconazole results in increased expression of SRGAP3 mRNA CTD PMID:35048155 Srgap3 Mouse quercetin increases expression ISO SRGAP3 (Homo sapiens) 6480464 Quercetin results in increased expression of SRGAP3 mRNA CTD PMID:21632981 Srgap3 Mouse resveratrol increases expression ISO SRGAP3 (Homo sapiens) 6480464 resveratrol results in increased expression of SRGAP3 mRNA CTD PMID:23137833 Srgap3 Mouse S-(1,2-dichlorovinyl)-L-cysteine multiple interactions ISO SRGAP3 (Homo sapiens) 6480464 S-(1 and 2-dichlorovinyl)cysteine inhibits the reaction [Lipopolysaccharides results in decreased expression of SRGAP3 mRNA] CTD PMID:35811015 Srgap3 Mouse SB 431542 multiple interactions ISO SRGAP3 (Homo sapiens) 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SRGAP3 mRNA CTD PMID:27188386 Srgap3 Mouse silicon dioxide decreases expression ISO SRGAP3 (Homo sapiens) 6480464 Silicon Dioxide analog results in decreased expression of SRGAP3 mRNA CTD PMID:25895662 Srgap3 Mouse silver atom decreases expression ISO SRGAP3 (Homo sapiens) 6480464 Silver results in decreased expression of SRGAP3 mRNA CTD PMID:26551752 Srgap3 Mouse silver(0) decreases expression ISO SRGAP3 (Homo sapiens) 6480464 Silver results in decreased expression of SRGAP3 mRNA CTD PMID:26551752 Srgap3 Mouse sodium arsenate multiple interactions ISO SRGAP3 (Homo sapiens) 6480464 [sodium arsenate results in increased abundance of Arsenic] which results in increased expression of SRGAP3 mRNA CTD PMID:32525701 Srgap3 Mouse sodium arsenite increases expression ISO SRGAP3 (Homo sapiens) 6480464 sodium arsenite results in increased expression of SRGAP3 mRNA CTD PMID:29301061 Srgap3 Mouse sodium arsenite decreases expression ISO SRGAP3 (Homo sapiens) 6480464 sodium arsenite results in decreased expression of SRGAP3 mRNA CTD PMID:38568856 Srgap3 Mouse sulforaphane decreases expression ISO SRGAP3 (Homo sapiens) 6480464 sulforaphane results in decreased expression of SRGAP3 mRNA CTD PMID:31838189 Srgap3 Mouse thiram decreases expression ISO SRGAP3 (Homo sapiens) 6480464 Thiram results in decreased expression of SRGAP3 mRNA CTD PMID:38568856 Srgap3 Mouse titanium dioxide multiple interactions EXP 6480464 [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of SRGAP3 mRNA CTD PMID:29950665 Srgap3 Mouse titanium dioxide decreases methylation EXP 6480464 titanium dioxide results in decreased methylation of SRGAP3 gene CTD PMID:35295148 Srgap3 Mouse trichostatin A affects expression ISO SRGAP3 (Homo sapiens) 6480464 trichostatin A affects the expression of SRGAP3 mRNA CTD PMID:28542535 Srgap3 Mouse trimellitic anhydride decreases expression EXP 6480464 trimellitic anhydride results in decreased expression of SRGAP3 mRNA CTD PMID:19042947 Srgap3 Mouse triptonide decreases expression EXP 6480464 triptonide results in decreased expression of SRGAP3 mRNA CTD PMID:33045310 Srgap3 Mouse trovafloxacin increases expression EXP 6480464 trovafloxacin results in increased expression of SRGAP3 mRNA CTD PMID:35537566 Srgap3 Mouse valproic acid increases methylation ISO SRGAP3 (Homo sapiens) 6480464 Valproic Acid results in increased methylation of SRGAP3 gene CTD PMID:29154799 Srgap3 Mouse valproic acid decreases expression ISO Srgap3 (Rattus norvegicus) 6480464 Valproic Acid results in decreased expression of SRGAP3 mRNA CTD PMID:29427782 Srgap3 Mouse valproic acid affects splicing ISO Srgap3 (Rattus norvegicus) 6480464 Valproic Acid affects the splicing of SRGAP3 mRNA CTD PMID:29427782 Srgap3 Mouse valproic acid decreases expression ISO SRGAP3 (Homo sapiens) 6480464 Valproic Acid results in decreased expression of SRGAP3 mRNA CTD PMID:28001369 Srgap3 Mouse valproic acid increases expression ISO SRGAP3 (Homo sapiens) 6480464 Valproic Acid results in increased expression of SRGAP3 mRNA CTD PMID:23179753 Srgap3 Mouse valproic acid affects expression ISO SRGAP3 (Homo sapiens) 6480464 Valproic Acid affects the expression of SRGAP3 mRNA CTD PMID:25979313 Srgap3 Mouse vinclozolin increases methylation ISO Srgap3 (Rattus norvegicus) 6480464 vinclozolin results in increased methylation of SRGAP3 gene CTD PMID:31682807 Srgap3 Mouse zoledronic acid increases expression ISO SRGAP3 (Homo sapiens) 6480464 zoledronic acid results in increased expression of SRGAP3 mRNA CTD PMID:24714768